Cell-Penetrating Antimicrobial Peptides Derived from an Atypical Staphylococcal δ-Toxin

Overview

Journal Microbiol Spectr

Specialty Microbiology

Date 2021 Dec 23

PMID 34937169

Citations 1

Authors

Kathyana Deeyagahage

Antonio Ruzzini

Affiliations

Soon will be listed here.

Abstract

Revisiting underutilized classes of antibiotics is a pragmatic approach to the identification of alternative therapies for antimicrobial-resistant pathogens. To this end, we designed and screened a set of seven staphylococcal δ-toxin-inspired peptides (STIPs) for antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). Furthermore, a pathogen-specific protease was leveraged to generate shorter peptides from these δ-toxin derivatives to expand the screen of putative antimicrobial peptides (AMPs) and to counterscreen against AMP inactivation. Remarkably, a 17-amino acid peptide based on the atypical δ-toxin sequence of Staphylococcus auricularis was discovered to possess an ability to kill MRSA and related pathogens. An alanine scan and series of rational substitutions improved AMP activity, and phenotypic assays characterized the STIPs' ability to rapidly interact with and permeabilize the staphylococcal membrane without causing lysis on a commensurate timescale. Instead of rapid lysis, both l- and d-enantiomers of STIP3-29, an AMP with low micromolar activity, were observed to penetrate and accumulate within cells. Finally, we observed that STIP3-29 was capable of controlling MRSA infection in a three-dimensional skin infection model. Overall, the results suggest that this unconventional source of AMPs can provide promising candidates for further development as therapeutic agents. The continued emergence and global distribution of infections caused by antimicrobial-resistant pathogens fuel our perpetual need for new or alternative therapies. Here, we present the discovery and initial characterization of bacterial cell-penetrating AMPs that were based on a family of virulence factors. In contrast to the multitude of AMPs that are sourced from animals, these potential therapeutic molecules have not undergone extensive selection for their antimicrobial properties and have proven to be amenable to activity-optimizing modifications. The staphylococcal toxin-inspired peptides described here represent a source of AMPs that can kill common opportunistic pathogens, such as MRSA, and have the potential to be improved for application in medicine.

Citing Articles

Inhibition of Clinical MRSA Isolates by Coagulase Negative Staphylococci of Human Origin.

Twomey E, OConnor P, Coffey A, Kiste M, Guinane C, Hill C Antibiotics (Basel). 2024; 13(4).

PMID: 38667016 PMC: 11047365. DOI: 10.3390/antibiotics13040338.

References

Wang G, Hanke M, Mishra B, Lushnikova T, Heim C, Thomas V . Transformation of human cathelicidin LL-37 into selective, stable, and potent antimicrobial compounds. ACS Chem Biol. 2014; 9(9):1997-2002. PMC: 4168778. DOI: 10.1021/cb500475y. View

Al-Mahrous M, Sandiford S, Tagg J, Upton M . Purification and characterization of a novel delta-lysin variant that inhibits Staphylococcus aureus and has limited hemolytic activity. Peptides. 2010; 31(9):1661-8. DOI: 10.1016/j.peptides.2010.06.006. View

de Breij A, Riool M, Cordfunke R, Malanovic N, de Boer L, Koning R . The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med. 2018; 10(423). DOI: 10.1126/scitranslmed.aan4044. View

Tayeb-Fligelman E, Salinas N, Tabachnikov O, Landau M . Staphylococcus aureus PSMα3 Cross-α Fibril Polymorphism and Determinants of Cytotoxicity. Structure. 2020; 28(3):301-313.e6. DOI: 10.1016/j.str.2019.12.006. View

Verdon J, Berjeaud J, Lacombe C, Hechard Y . Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri. Peptides. 2008; 29(6):978-84. DOI: 10.1016/j.peptides.2008.01.017. View

Haney E, Straus S, Hancock R . Reassessing the Host Defense Peptide Landscape. Front Chem. 2019; 7:43. PMC: 6369191. DOI: 10.3389/fchem.2019.00043. View

Kreger A, Kim K, Zaboretzky F, BERNHEIMER A . Purification and properties of staphylococcal delta hemolysin. Infect Immun. 1971; 3(3):449-65. PMC: 416173. DOI: 10.1128/iai.3.3.449-465.1971. View

Cherry M, Higgins S, Melroy H, Lee H, Pokorny A . Peptides with the same composition, hydrophobicity, and hydrophobic moment bind to phospholipid bilayers with different affinities. J Phys Chem B. 2014; 118(43):12462-70. PMC: 4234449. DOI: 10.1021/jp507289w. View

Magana M, Pushpanathan M, Santos A, Leanse L, Fernandez M, Ioannidis A . The value of antimicrobial peptides in the age of resistance. Lancet Infect Dis. 2020; 20(9):e216-e230. DOI: 10.1016/S1473-3099(20)30327-3. View

10.

Cogen A, Yamasaki K, Sanchez K, Dorschner R, Lai Y, MacLeod D . Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol. 2009; 130(1):192-200. PMC: 2796468. DOI: 10.1038/jid.2009.243. View

11.

Schneider C, Rasband W, Eliceiri K . NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9(7):671-5. PMC: 5554542. DOI: 10.1038/nmeth.2089. View

12.

Tayeb-Fligelman E, Tabachnikov O, Moshe A, Goldshmidt-Tran O, Sawaya M, Coquelle N . The cytotoxic PSMα3 reveals a cross-α amyloid-like fibril. Science. 2017; 355(6327):831-833. PMC: 6372758. DOI: 10.1126/science.aaf4901. View

13.

Schwartz K, Syed A, Stephenson R, Rickard A, Boles B . Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog. 2012; 8(6):e1002744. PMC: 3369951. DOI: 10.1371/journal.ppat.1002744. View

14.

Baldry M, Bojer M, Najarzadeh Z, Vestergaard M, Meyer R, Otzen D . Phenol-Soluble Modulins Modulate Persister Cell Formation in . Front Microbiol. 2020; 11:573253. PMC: 7680730. DOI: 10.3389/fmicb.2020.573253. View

15.

Kang X, Dong F, Shi C, Liu S, Sun J, Chen J . DRAMP 2.0, an updated data repository of antimicrobial peptides. Sci Data. 2019; 6(1):148. PMC: 6692298. DOI: 10.1038/s41597-019-0154-y. View

16.

Wade D, Boman A, Wahlin B, Drain C, Andreu D, Boman H . All-D amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci U S A. 1990; 87(12):4761-5. PMC: 54197. DOI: 10.1073/pnas.87.12.4761. View

17.

Dhople V, Nagaraj R . Conformation and activity of delta-lysin and its analogs. Peptides. 2005; 26(2):217-25. DOI: 10.1016/j.peptides.2004.09.013. View

18.

Joo H, Cheung G, Otto M . Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem. 2011; 286(11):8933-40. PMC: 3059065. DOI: 10.1074/jbc.M111.221382. View

19.

Somayaji R, Priyantha M, Rubin J, Church D . Human infections due to Staphylococcus pseudintermedius, an emerging zoonosis of canine origin: report of 24 cases. Diagn Microbiol Infect Dis. 2016; 85(4):471-6. DOI: 10.1016/j.diagmicrobio.2016.05.008. View

20.

Marchand A, Verdon J, Lacombe C, Crapart S, Hechard Y, Berjeaud J . Anti-Legionella activity of staphylococcal hemolytic peptides. Peptides. 2011; 32(5):845-51. DOI: 10.1016/j.peptides.2011.01.025. View